Second-Generation Antipsychotic Medications in Children and Adolescents

Cheng-Shannon, Jennifer, McGough, James J., Pataki, Caroly, McCracken, James T.·2004·Journal of Child and Adolescent Psychopharmacology

Cited by (153)

Items 101–153 of 153

  1. The use of antipsychotics in children and adolescents with bipolar disorders
    Jonathan C. Pfeifer, Robert A. Kowatch, Melissa P. DelBello · 2007 · Expert Opinion on Pharmacotherapy
  2. Gaining: Pediatric Patients and Use of Atypical Antipsychotics
    Kenneth E. Towbin · 2006 · American Journal of Psychiatry
  3. Neurological Adverse Effects of Antipsychotic Medication in Children and Young People
    Frank Besag, Michael J. Vasey, Chris P. Hollis, David M. Taylor · 2026 · Pediatric Drugs
  4. Multiple Psychiatric Diagnoses Common in Privately Insured Children on Atypical Antipsychotics
    Donna R. Halloran, Jason P. Swindle, Steve K. Takemoto, Mark A. Schnitzler · 2010 · Clinical Pediatrics
  5. Self-reported Side Effects in children and Adolescents Taking Risperidone
    Simon Byrne, Garry Walter, Glenn E. Hunt, Nerissa Li‐Wey Soh, Michelle L. Cleary, P. Reid Duffy, Geoff Crawford, Peter Krabman, Patrick Concannon, Gin Singh Malhi · 2010 · Australasian Psychiatry
  6. Current Neuropharmacological Interventions in Autism: Potential Drug Targets from Pre-clinical and Clinical Findings
    Ramit Sharma, Aarti Tiwari, Saloni Rahi, Sidharth Mehan · 2020 · Current Psychopharmacologye
  7. Managing Psychotic Illness in Young People: A Practical Overview
    Paul Alexander Tiffin · 2006 · Child and Adolescent Mental Health
  8. Autism Spectrum Disorders
    Chris Plauché Johnson, Scott M. Myers · 2008 · Elsevier eBooks
  9. Comparison between the efficacies of Risperidone with Haloperidol in the treatment of attention-deficit hyperactivity disorder (ADHD) among preschoolers: a randomized double-blind clinical trial
    Forough Riahi, Ashraf Tashakori, Leila Abdi · 2016 · Electronic physician
  10. Effect of an online healthy lifestyle psychoeducation programme to improve cardiometabolic outcomes and affective symptoms in youth receiving mental health care: study protocol for a pilot clinical trial.
    Chloe E. Wilson, Alissa Nichles, Natalia Zmicerevska, Joanne Sarah Carpenter, Yun Ju Christine Song, Catherine M. McHugh, Blake A. Hamilton, Samuel James Hockey, Elizabeth M. Scott, Ian Bernard Hickie · 2021 · BMJ Open
  11. Age, Race, and Gender Differences in Antipsychotic Medication Use Among Children Prior to Entry to Out-of-Home Care
    John M. Robst, Mary I. Armstrong, Norín Dollard · 2009 · Residential Treatment for Children & Youth
  12. Personality analysis of patients complaining of sialorrhoea
    P.‐J. Lamey, Thomas Clifford, Ikhlas A. El Karim, Colin Cooper · 2006 · Journal of Oral Pathology and Medicine
  13. Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents
    David Fraguas, Jessica Merchán‐Naranjo, Celso Arango · 2010 · Revista de Psiquiatría y Salud Mental (English Edition)
  14. How to Make Effective Evaluation of Psychotropic Drug Effects in People with Developmental Disabilities and Self-Injurious Behavior
    Stephen R. Schroeder, Jessica A. Hellings, Andrea B. Courtemanche · 2013 · Issues in clinical child psychology
  15. Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999–2003
    Scott C. Flanders, Robert L. Findling, Eric Arden Youngstrom, Gahan Pandina, Marcia F.T. Rupnow, Sarah E Jensik, Gabrielle A. Carlson · 2007 · Journal of Child and Adolescent Psychopharmacology
  16. Pharmakotherapie bipolarer Störungen im Kindes- und Jugendalter
    Jennifer Anne Vloet, Ulrich Hagenah · 2009 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
  17. Effectiveness of lifestyle interventions for preventing or managing the adverse cardiometabolic and other physical health effects of antipsychotic medications in children and adolescents: systematic review and meta-analysis
    Patrick Hawker, Jessica Bellamy, Tsz-Ying Wong, Catherine McHugh, Philip B. Ward, Amanda Wood, B. Tonge, Katrina Williams, M. Bellgrove, T. Silk et al. · 2025 · BJPsych Open
  18. Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint: A Preliminary Exploratory Retrospective Chart Review
    Cecilia Albers, Neetu Nair, Ravi Shankar · 2021 · Journal of Child and Adolescent Psychopharmacology
  19. Second generation antipsychotics & nocturnal enuresis in children
    Julie Thiel · 2013 · Mental Health Clinician
  20. Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder across the Life Span
    Jefferson B. Prince, Thomas J. Spencer, Timothy E. Wilens, Joseph Biederman · 2008 · Elsevier eBooks
  21. Les psychotropes en pédopsychiatrie et leur prescription hors AMM : une étude transversale en population clinique tunisienne
    M. Daoud, Fatma Charfi, F. Behi, Abir Ben Hamouda, Soumaya Bourgou, Ahlem Belhadj · 2022 · Neuropsychiatrie de l Enfance et de l Adolescence
  22. Atypical and typical antipsychotics in the schools
    Chad A. Noggle, Raymond S. Dean · 2009 · Psychology in the Schools
  23. A Descriptive Study of Use of Psychotropic Drugs in Child and Adolescent Psychiatric Illness in an Inpatient Facility
    Fahad Abdulwahab Jameel, Ashwin Kamath, Shripathy M. Bhat, Laxminarayana Kurady Bairy · 2012
  24. Addressing Faulty Prescribing Practices of Psychotropic Medication Among Court-Involved Children and Adolescents
    Nancy G. Calleja, Ann M. Dadah · 2018 · The Family Journal
  25. Aripiprazole in the treatment of early-onset schizophrenia spectrum disorder: A case series in Korean children and adolescents
    Yeni Kim, Soo-Churl Cho, Min‐Sup Shin, Jae-Won Kim, Sang‐Chul Choi, Boong‐Nyun Kim · 2009 · Current Therapeutic Research
  26. Real-world use of quetiapine in early psychosis: An acute inpatient and community follow-up effectiveness study
    Stanley Victor Catts, Aaron D. J. Frost, Shaune Gifford, James G. Scott · 2008 · International Journal of Psychiatry in Clinical Practice
  27. Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?
    Garry Walter, Simon Byrne, Oren Griffiths, Glenn E. Hunt, Nerissa Li‐Wey Soh, Michelle L. Cleary, P. Reid Duffy, Geoff Crawford, Peter Krabman, Patrick Concannon et al. · 2010 · Acta Neuropsychiatrica
  28. Schizophrenia among Children and Adolescents
    Jason Eric Schiffman · 2007 · Cambridge University Press eBooks
  29. Treatment Effectiveness of an Adolescent Residential Treatment Center for Males Using a Psychotropic Medication Reduction Protocol
    Sean Dodge · 2009 · CommonKnowledge Research Repository (Pacific University Oregon)
  30. Psychotropic drug utilization in psychiatry inpatients in a tertiary healthcare setting
    Ashwin Kamath, V Bheemesh, Sudarshan Reddy, Ravish Thunga · 2012 · International Journal of Medical & Pharmaceutical Sciences
  31. Effectiveness of lifestyle interventions for improving the physical health of children and adolescents taking antipsychotic medications: protocol for a systematic review and meta-analysis
    Patrick J. Hawker, Jessica Bellamy, Catherine M. McHugh, Tsz Ying Wong, Katrina Jane Williams, AMANDA G. WOOD, Vicki A. Anderson, Bruce John Tonge, Philip B. Ward, Emma Sciberras et al. · 2023 · BMJ Open
  32. Evaluation of the Safer Use of Antipsychotics in Youth Study on Population Level Antipsychotic Initiation: An Interrupted Time Series Analysis
    Laura M. West, Stephen J. Mooney, Laura J. Chavez, Arne L Beck, Gregory N. Clarke, Chester J. Pabiniak, Anne D. Renz, Robert B. Penfold · 2024 · Journal of Child and Adolescent Psychopharmacology
  33. Characteristics Associated With the Continuity of Atypical Antipsychotic Treatment Among Youth Discharged From Residential Treatment
    William Morea, John M. Robst · 2013 · Residential Treatment for Children & Youth
  34. Efectos adversos metabólicos y endocrinos de los antipsicóticos de segunda generación en niños y adolescentes: una revisión sistemática de ensayos aleatorizados, controlados con placebo y guías de práctica clínica
    M.A.F. De Hert, Marie Dobbelaere, E.M. Sheridan, Dan Cohen, Christoph Ulrich Correll · 2011 · Psiquiatría Biológica
  35. Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
    Antonio DEL CASALE, Georgios Demetrios Kotzalidis, Michele Sacco, Chiara Rapinesi, Riccardo De Giorgi, Marco Giardini, Michele D’Andreagiovanni, Nicola Carlino, Roberto Brugnoli, Paolo Girardi · 2016 · PubMed
  36. Neurobiology of Childhood-Onset Schizophrenia
    Parthasarathy Biswas · 2008 · Journal of Indian Association for Child and Adolescent Mental Health
  37. Psychopharmacology and juvenile delinquency
    Niranjan S. Karnik, Marie V. Soller, Hans Steiner · 2007 · Cambridge University Press eBooks
  38. Erfolgreiche Behandlung einer Early-onset-Schizophrenie mit Olanzapin
    D. Kölsch · 2011 · Nervenheilkunde
  39. Evidence based administration of risperidone and paliperidone for the treating conduct disorder.
    Ahmad Javid Ghanizadeh · 2013 · Europe PMC (PubMed Central)
  40. Factors Contributing to Weight Gain in Children Who Take Atypical Antipsychotics
    Martha J. Faulkner · 2014 · UNM’s Digital Repository (University of New Mexico)
  41. Social dysfunction and mental retardation
    Susanna Pietropaolo, Frans Sluyter, Wim E. Crusio · 2014 · Cambridge University Press eBooks
  42. Use of Atypical Antipsychotics in Children & Adolescents
    Robert H. Howland · 2005 · Journal of Psychosocial Nursing and Mental Health Services
  43. Farmacoepidemiología de psicofármacos empleados en la práctica pediátrica en el Servicio de Psiquiatría Infantil del Hospital General de Durango, México Pharmacoepidemiology of psychotropic drugs used in the service of child Psychiatry of the General Hospital of Durango, México
    Ismael Lares Asseff, Martha Sosa‐Macías, Rut E. Alanis Bañuelos, Pedro Ortiz Sánchez, Gabriela Guillé Pérez, Verónica Loera Castañeda, Carlos Galavíz-Hernández · 2010
  44. Obsessive–compulsive disorder and Gilles de la Tourette syndrome
    Nancy S. Woehrle, Stephanie C. Dulawa · 2014 · Cambridge University Press eBooks
  45. Explorations of the Use of Olanzapine for Management of Chemotherapy-induced Nausea and Vomiting in Children
    Jacqueline Flank · 2015 · TSpace (University of Toronto)
  46. TRATAMIENTO FARMACOLÓGICO DEL TDAH Y LAS COMORBILIDADES
    Jefferson B. Prince, Timothy E. Wilens · 2010 · Elsevier eBooks
  47. The Long-term Effects of Chronic Antipsychotic Drug Treatment in Juvenile Rats on Adult Behavioural Attributes, Dopamine and Serotonin Neurotransmitter Systems
    Michael De Santis · 2018 · Research Online (University of Wollongong)
  48. Pharmacology
    Francisco Ciruela, Rafael Franco, Javier Burgueño · 2007
  49. Опыт применения новых оригинальных мазей для лечения экспериментальной синегнойной инфекции ожоговых ран
    Геннадий Маркович Шуб, Алипов Владимир Владимирович, Лебедев Максим Сергеевич, Е. А. Добрейкин, Н. В. Алипов, Пронина Елена Александровна, Svetlana Vladimirovna Raikova, Шаповал Ольга Георгиевна · 2011 · DOAJ (DOAJ: Directory of Open Access Journals)
  50. Current awareness in human psychopharmacology
    2005 · Human Psychopharmacology Clinical and Experimental
  51. Antipsychotic Drug Poisoning in Children Under 12 Years Old in Loghman-Hakim Hospital During 2016-2022
    Fariba Farnaghi, Pooya Eini, Latif Gachkar · 2024 · International Journal of Medical Toxicology and Forensic Medicine
  52. Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients
    Kirsi Kakko, Raili K. Salmelin, Kaija Puura, Tuija Poutanen · 2025 · European Journal of Pediatrics
  53. Anwendungsgebiete neuerer Antipsychotika in der Behandlung von Kindern und Jugendlichen außerhalb des schizophrenen Spektrums
    Wolfgang Aichhorn, W. Wolfgang Fleischhacker · 2006 · Psychiatrie und Psychotherapie